๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Docetaxel cost effective as second-line therapy in NSCLC

โœ Scribed by Greener, Mark


Book ID
121643063
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2002
Weight
136 KB
Volume
357
Category
Article
ISSN
1173-5503

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES